本页面由Tiger Trade Technology Pte. Ltd.提供服务

再生元制药公司

746.00
-7.9300-1.05%
盘后743.00-3.0000-0.40%19:45 EDT
成交量:50.54万
成交额:3.78亿
市值:788.67亿
市盈率:17.94
高:756.00
开:749.56
低:742.69
收:753.93
52周最高:821.11
52周最低:476.49
股本:1.06亿
流通股本:1.03亿
量比:0.76
换手率:0.49%
股息:3.52
股息率:0.47%
每股收益(TTM):41.59
每股收益(LYR):41.48
净资产收益率:14.87%
总资产收益率:5.91%
市净率:2.52
市盈率(LYR):17.98

数据加载中...

2024/08/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/07/08

重要事件披露

Form 8-K - Current report
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/20

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/21

SEC问询函

Form CORRESP - Correspondence
2024/05/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/02

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities